Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Fortrea Holdings (NASDAQ:FTRE) through any online brokerage.
Other companies in Fortrea Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Fortrea Holdings has a consensus price target of $19.35.
The stock price for Fortrea Holdings (NASDAQ: FTRE) is $20.37 last updated October 8, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Fortrea Holdings.
Fortrea Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Fortrea Holdings.
Fortrea Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.